Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Doherty

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Biochemical Society Transactions|September 17, 2009
GRAF1-dependent endocytosisGary J Doherty, Richard Lundmark
ESMO Open|December 7, 2017
Activating HER2 mutations as emerging targets in multiple solid cancersClaire M Connell, Gary J Doherty
Annual Review of Biochemistry|March 26, 2009
Mechanisms of endocytosisGary J Doherty, Harvey T McMahon
Annual Review of Biophysics|June 25, 2008
Mediation, modulation, and consequences of membrane-cytoskeleton interactionsGary J Doherty, Harvey T McMahon
Mechanisms of Ageing and Development|January 6, 2022
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cellsSamir Morsli, Gary J Doherty, Daniel Muñoz-Espín
British Journal of Cancer|February 24, 2021
Cannabinoids in glioblastoma multiforme-hype or hope?Gary J Doherty, Bruno H R de Paula
Future Oncology (London, England)|December 14, 2017
HALO-109-301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancerGary J Doherty, Margaret Tempero, Pippa G Corrie
BMJ Case Reports|September 1, 2017
Primary mediastinal seminoma presenting with superior vena caval obstructionMareike K Thompson, Deirdre M Lynskey, Gary J Doherty
Trends in Molecular Medicine|April 5, 2017
KRAS Allelic Imbalance: Strengths and Weaknesses in NumbersGary J Doherty, Emma M Kerr, Carla P Martins
Nature Cancer|February 5, 2022
Rethinking cancer clinical trials for COVID-19 and beyondGary J Doherty, Mehmet Goksu, Bruno H R de Paula
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Biochemical Society Transactions|September 17, 2009
GRAF1-dependent endocytosisGary J Doherty, Richard Lundmark
ESMO Open|December 7, 2017
Activating HER2 mutations as emerging targets in multiple solid cancersClaire M Connell, Gary J Doherty
Annual Review of Biochemistry|March 26, 2009
Mechanisms of endocytosisGary J Doherty, Harvey T McMahon
Annual Review of Biophysics|June 25, 2008
Mediation, modulation, and consequences of membrane-cytoskeleton interactionsGary J Doherty, Harvey T McMahon
Mechanisms of Ageing and Development|January 6, 2022
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cellsSamir Morsli, Gary J Doherty, Daniel Muñoz-Espín
British Journal of Cancer|February 24, 2021
Cannabinoids in glioblastoma multiforme-hype or hope?Gary J Doherty, Bruno H R de Paula
Future Oncology (London, England)|December 14, 2017
HALO-109-301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancerGary J Doherty, Margaret Tempero, Pippa G Corrie
BMJ Case Reports|September 1, 2017
Primary mediastinal seminoma presenting with superior vena caval obstructionMareike K Thompson, Deirdre M Lynskey, Gary J Doherty
Trends in Molecular Medicine|April 5, 2017
KRAS Allelic Imbalance: Strengths and Weaknesses in NumbersGary J Doherty, Emma M Kerr, Carla P Martins
Nature Cancer|February 5, 2022
Rethinking cancer clinical trials for COVID-19 and beyondGary J Doherty, Mehmet Goksu, Bruno H R de Paula
Pageof 4